Drugmaker Wockhardt is reportedly in ‘advanced stages of discussions for a deal related to Covid-19 drugs and vaccine. "The Company is in the process of negotiating manufacturing options for Covid -19 vaccine with global Vaccine developers as part of its normal pharmaceutical business. "Since the relevant agreements are not yet fully finalised, the same has not been informed to the Stock exchanges," Wockhardt Ltd said. For the financial year ended March this year, the company posted a net profit of ₹688.60 crore. The company posted a loss of ₹43.39 crore for the previous financial year, Wockhardt said.

Source: Mint June 04, 2021 03:22 UTC